Good response to second-line bevacizumab and interferon-alpha in a sunitinib ... - UroToday |
|
|
UroToday... such as bevacizumab, sunitinib, sorafenib, temsirolimus, and everolimus, the treatment of metastatic renal cell carcinoma has changed dramatically. ...
|